Cite

HARVARD Citation

    Fang, C. et al. (2021). EIF4E-eIF4G complex inhibition synergistically enhances the effect of sorafenib in hepatocellular carcinoma. Anti-cancer drugs. 32 (8), p. . [Online]. 
  
Back to record